Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 26;49(1):15.
doi: 10.1186/s13052-023-01418-7.

Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP

Valeria Dipasquale  1 , Marco Deganello Saccomani  2 , Angelo Di Giorgio  3 , Salvatore Oliva  4 , Silvia Salvatore  5 , Caterina Strisciuglio  6 , Renato Tambucci  7 , Paolo Lionetti  8 , Claudio Romano  1
Affiliations
Review

Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP

Valeria Dipasquale et al. Ital J Pediatr. .

Abstract

Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.

Keywords: Anti-TNF-α; COVID-19; Digestive endoscopy; Hepatitis; Inflammatory bowel disease; Liver disease; Pediatrics; SARS-CoV-2; SIGENP; Telemedicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. Dawood FS, Porucznik CA, Veguilla V, Stanford JB, Duque J, Rolfes MA, et al. Incidence rates, household infection risk, and clinical characteristics of SARS-CoV-2 infection among children and adults in Utah and New York City. New York JAMA Pediatrics. 2022;176:59–67. doi: 10.1001/jamapediatrics.2021.4217. - DOI - PMC - PubMed
    1. Yoshida M, Worlock KB, Huang N, Lindeboom RGH, Butler CR, Kumasaka N, et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature. 2022;602:321–327. doi: 10.1038/s41586-021-04345-x. - DOI - PMC - PubMed
    1. Salvatore S, Marinoni M, Agosti M. Additional concerns regarding children with Coronavirus Disease 2019. JAMA Pediatr. 2020;174:1217–1218. doi: 10.1001/jamapediatrics.2020.2922. - DOI - PubMed
    1. Dipasquale V, Passanisi S, Cucinotta U, Cascio A, Romano C. Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease. Ital J Pediatr. 2021;47:71. doi: 10.1186/s13052-021-01020-9. - DOI - PMC - PubMed